Anti-CD44 antibody treatment lowers hyperglycemia and improves insulin resistance, adipose inflammation, and hepatic steatosis in diet-induced obese mice

Authors :: Butte, Atul
Kodama, K
Toda, K
Morinaga, S
Yamada, S
Butte, AJ
Source :: Butte, Atul; Kodama, K; Toda, K; Morinaga, S; Yamada, S; & Butte, AJ. (2015). Anti-CD44 antibody treatment lowers hyperglycemia and improves insulin resistance, adipose inflammation, and hepatic steatosis in diet-induced obese mice.. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/2m69g8v0
Publication Year :: 2015
Publisher :: eScholarship, University of California, 2015.
Abstract: Type 2 diabetes (T2D) is a metabolic disease affecting >370 million people worldwide. It is characterized by obesity-induced insulin resistance, and growing evidence has indicated that this causative link between obesity and insulin resistance is associate

Language :: English
Database :: OpenAIRE
Journal :: Butte, Atul; Kodama, K; Toda, K; Morinaga, S; Yamada, S; & Butte, AJ. (2015). Anti-CD44 antibody treatment lowers hyperglycemia and improves insulin resistance, adipose inflammation, and hepatic steatosis in diet-induced obese mice.. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/2m69g8v0
Accession number :: edsair.od.......325..2f2b37487dc54fa464e46aaeee587974

Tools